[Usefulness of SPECT images in helping radiologists understand brain diseases].
Nuclear brain imaging is able to show functional abnormalities of lesions that are not detectable by CT and MR images. The diagnostic keys of nuclear-imaging in terms of clinical usefulness are its early detection of lesions and determination of the efficacy of drug and surgical therapies. In dementic patients, F-18 FDG brain images can be diagnosed as Alzheimer's disease 12 months earlier than is possible on CT and MRI images, and can provide information for effective drug therapy. O-15 water CBF images can predict the effect of Nicholin by assessing transient increases in cerebral blood flow (CBF), thereby facilitating improvement in higher brain functions such as orientation. In stroke patients, brain SPECT images with Tc-99m HMPAO can predict fatal cerebral hemorrhage caused by anti-thrombic therapy by showing the decrease in count ratio (count ratio of infarcted to contralateral area of < 0.34) in the acute phase and identifying disruption of the blood brain barrier by showing hyperfixation in the subacute phase. Brain SPECT with I-123 IMP can also identify "misery" perfused areas resulting from reduced CBF and decreased vasoreactivity in the chronic phase. This criterion is utilized for patient selection for extracranial/intracranial bypass surgery, because patients with areas of poor perfusion might be indicated for such surgery. Since nuclear medicine images can accurately select candidates for drug or surgical therapies, they will be beneficial in reducing Medicare costs as well as in enhancing patients' quality of life as a result of the successful treatment. With the advancement of technology, nuclear medicine units that can simultaneously obtain CT images and can combine functional with anatomical images will provide more useful information for the diagnosis of brain disease.